Cimetidine
| Clinical data | |
|---|---|
| Pronunciation | /sɪˈmɛtɪdiːn/ or /saɪˈmɛtɪdiːn/ |
| Trade names | Tagamet, others |
| Other names | SKF-92334[1] |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682256 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | By mouth, intramuscular injection, intravenous infusion[2] |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 60–70%[5][6] |
| Protein binding | 13–25%[6][7] |
| Metabolism | Liver[6] |
| Metabolites | • Cimetidine sulfoxide[6] • Hydroxycimetidine[6] • Guanyl urea cimetidine[6] |
| Onset of action | 30 minutes[8] |
| Elimination half-life | 123 minutes (~2 hours)[7] |
| Duration of action | 4–8 hours[2] |
| Excretion | Urine[7] |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.052.012 |
| Chemical and physical data | |
| Formula | C10H16N6S |
| Molar mass | 252.34 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Cimetidine, sold under the brand name Tagamet among others, is a histamine H2 receptor antagonist that inhibits stomach acid production.[1][9][10] It is mainly used in the treatment of heartburn and peptic ulcers.[1][10][11]
With the development of proton pump inhibitors, such as omeprazole, approved for the same indications, cimetidine is available as an over-the-counter formulation to prevent heartburn or acid indigestion, along with the other H2-receptor antagonists.[12]
Cimetidine was developed in 1971 and came into commercial use in 1977.[13][14] Cimetidine was approved in the United Kingdom in 1976, and was approved in the United States by the Food and Drug Administration in 1979.[15]
- ^ a b c Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Bibliographies. Springer. pp. 275–. ISBN 978-1-4757-2085-3.
- ^ a b Gupta A, Singh-Radcliff N (12 March 2013). Pharmacology in Anesthesia Practice. Oxford University Press. pp. 177–. ISBN 978-0-19-934399-7.
- ^ "Cimetidine tablet, film coated". DailyMed. 30 November 2022. Retrieved 24 June 2024.
- ^ "Tagamet - cimetidine tablet". DailyMed. 10 June 2024. Retrieved 24 June 2024.
- ^ Dowd FJ, Johnson B, Mariotti A (3 September 2016). Pharmacology and Therapeutics for Dentistry - E-Book. Elsevier Health Sciences. pp. 406–. ISBN 978-0-323-44595-5.
- ^ a b c d e f Cite error: The named reference
LeikinPaloucek1995was invoked but never defined (see the help page). - ^ a b c Profiles of Drug Substances, Excipients and Related Methodology. Academic Press. 24 October 1984. pp. 176–. ISBN 978-0-08-086108-1.
- ^ Cite error: The named reference
VallerandSanoski2016was invoked but never defined (see the help page). - ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 234–. ISBN 978-3-88763-075-1.
- ^ a b Morton I, Morton IK, Hall JM (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 77–. ISBN 978-0-7514-0499-9.
- ^ Jacqueline B, Rosenthal L (2 December 2014). "Drugs for Peptic Ulcer Disease". Lehne's Pharmacology for Nursing Care. Elsevier Health Sciences. pp. 952–. ISBN 978-0-323-34026-7.
- ^ Pino MA, Azer SA (March 2023). "Cimetidine". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 31334975. Bookshelf ID: NBK544255. Retrieved 6 November 2023 – via U.S. National Library of Medicine.
- ^ Fischer J, Ganellin CR (24 August 2010). Analogue-based Drug Discovery II. John Wiley & Sons. p. 4. ISBN 978-3-527-63212-1.
- ^ Alapi EM, Fischer J (2006). "Table of Selected Analogue Classes". In Fischer J, Ganellin CR (eds.). Analogue-based Drug Discovery. John Wiley & Sons. p. 444. ISBN 9783527607495.
- ^ "Tagamet: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 30 April 2017. Retrieved 9 November 2023.